Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCT650C in moderate-to-severe plaque psoriasis
CTR20240593Phase 2Active
- Sponsor
- Sinocelltech Group Limited
- Start
- Feb 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of SCT650C in plaque psoriasis, sponsored by Sinocelltech Group Limited. Started Feb 2024; status: active.
02
Drugs
SCT650C
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20240593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240593.